With Walgreens Exiting Primary Care, VillageMD Has Hundreds Of Sites To Sell

VillageMD Seeks New Buyers for Doctor Practices and Clinics Following Walgreens’ Change in Strategy

With Walgreens no longer pursuing a primary care strategy under its new owner, VillageMD is now actively seeking new buyers for potentially hundreds of doctor practices and outpatient clinics across the country. This move comes after VillageMD was sold to private equity firm Sycamore Partners in a $10 billion takeover of Walgreens.

VillageMD, which operates as a standalone company following the acquisition, has a vast network of physician practices, outpatient health centers, urgent care sites, and clinics located adjacent to Walgreens stores. The company is now in the process of identifying potential buyers for these assets, with hopes of securing a favorable sale price given the terms of the acquisition by Sycamore.

As part of the deal, Walgreens investors will receive additional cash consideration from the future monetization of Walgreens’ interests in VillageMD, which includes the Village Medical, Summit Health, and CityMD businesses. This strategic move aims to maximize the value of VillageMD’s assets and generate returns for stakeholders.

VillageMD’s portfolio includes over 130 practices under the Village Medical brand, with approximately 90 clinics located near Walgreens drugstores. Additionally, CityMD operates more than 185 clinics, Summit Health has over 130 locations, and Starling Physicians has more than 20 practices. The company’s diverse range of healthcare facilities presents an attractive investment opportunity for potential buyers.

Walgreens’ initial investment in VillageMD was substantial, totaling billions of dollars under former CEO Roz Brewer. However, the drugstore chain later scaled back its expansion of doctor practices and clinics due to challenges in filling patient panels. This decision, coupled with financial losses incurred by Walgreens, led to a shift in strategy and the eventual sale of VillageMD to Sycamore Partners.

The departure of VillageMD’s founder and CEO Tim Barry, along with Walgreens’ decision to reduce its investment in the primary care company, further underscored the challenges faced by the partnership. Despite these setbacks, VillageMD remains a valuable asset with a strong presence in the healthcare market.

In conclusion, VillageMD’s search for new buyers reflects a strategic realignment following Walgreens’ change in direction. The company’s extensive network of doctor practices and clinics presents a lucrative opportunity for investors looking to capitalize on the growing demand for primary care services. As VillageMD transitions to new ownership, the future of its healthcare facilities remains promising in an evolving industry landscape.